Study reveals that mRNA vaccines could produce mad cow disease!
WASHINGTON (PNN) - April 17, 2021 - A research article published by J. Bart Classen, MD, argues that mRNA-based vaccines could produce adverse effects generated by prions (infectious agents), including several neurodegenerative diseases such as mad cow disease.
In this regard, analysis of Pfizer’s COVID “vaccine” identified two potential risk factors for inducing prion disease in humans.
The RNA sequence in the vaccine would cause these health problems, which would only occur three to four years after being injected into patients.
Messenger RNA or mRNA is the ribonucleic acid that determines the order in which the amino acids of a protein will be joined, and acts as a template for its synthesis.
One of the prion diseases is bovine spongiform encephalopathy (BSE) or mad cow disease, which destroys brain tissue, is degenerative, transmissible, and fatal.
Likewise, Alzheimer’s disease and amyotrophic lateral sclerosis (ALS) affect the nervous system, weakening muscles and physical functions. Another is degenerative dementia associated with the TDP-43 protein.
Also included is the risk that diabetes 1 will be induced at a more numerous frequency than the serious infectious diseases the “vaccine” was intended to prevent.
Worse, Classen supports those who claim that the viral spike protein in the “vaccine” was designed to cause prion disease.
By placing an identical receptor - the spike protein - in the cells of all human beings, the genetic diversity that protects the species naturally disappears.
In wanting to cause widespread damage to all people, a second and potentially more dangerous virus can then be launched that binds to the spike protein, which is found in the host cells of the “vaccine” recipients.
The fact that this research, which could be used for bioweapons development, is funded by private organizations including the Bill and Melinda Gates Foundation and Ellison Medical Foundation, without national/international oversight is also a concern.
Adverse effects have been common to vaccines of all brands, with Germany’s health department reporting another seven deaths and at least 21 cases of blood clots in people who recently received AstraZeneca’s CCV “vaccine”, of which seven died as a result.
After several European countries suspended the AstraZeneca vaccine in early March, citing severe adverse effects and the presence of dangerous associated blood clots, the European Medicines Agency (EMA) finally reaffirmed the safety and efficacy of the “vaccine”. However, it cautioned that it could not rule out the possibility that it may cause blood clots.
At a March 18 press conference, without elaborating further, EMA officials said their research could not rule out a connection between the “vaccine” and certain unusual clotting and bleeding disorders. But in their view, the benefits of the “vaccine” would outweigh the risks.